Vietnam MOH registration 230001931/PCBA-HN

CALCIUM LIPOSOME BABY

Vietnam·Risk Class TTBYT Loại A·CALCIUM LIPOSOME BABY·MEDYPHARM Central Pharmaceutical Corporation·Registered Oct 06, 2023

Registration details

Analysis ID: 230001931/PCBA-HN
Submission ID: 000.00.19.H26-231005-0020
Product Type: CALCIUM LIPOSOME BABY

Company information

Manufacturer: MEDYPHARM Central Pharmaceutical Corporation
Manufacturer Country: VIET NAM

Technical details

Intended Use: Calcium helps children absorb a large amount of calcium in a short period of time, supporting bone and teeth health, which is a crucial step in helping children grow taller. It helps prevent constipation in children, laying the foundation for their growth. It is recommended for children during the growth and development stage, supporting their health and bone strength, and treating and preventing osteoporosis. It helps reduce bone pain and inflammation during movement and speeds up the healing of bone fractures. Calcium has a regulatory effect on heart function, improves memory, and reduces the incidence of night crying in children.

Dates and status

Registration Date: Oct 06, 2023

About this record

Access comprehensive regulatory information for CALCIUM LIPOSOME BABY in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại A medical device is registered under number 230001931/PCBA-HN and manufactured by MEDYPHARM Central Pharmaceutical Corporation.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.